420 with CNW — How Is Marijuana Legalization Impacting Real Estate Prices?

The cannabis industry has come a long way from the days when states that didn’t criminalize the controversial drug were the exception rather than the norm. Now, 36 states have legalized medical use, 15 allow recreational use, and several more are considering cannabis legalization for the future. The road to legalization wasn’t easy, however, with most opponents arguing legalization would increase crime rates as well as cannabis and subsequent drug use among children.

Years later, we can see that most of those fears were unfounded. However, although marijuana legalization policies haven’t increased criminal activity or youth drug use, they have had quite an interesting effect on real estate, a report from the National Association of Realtors (“NAR”) says. In states where medical and recreational marijuana has been legal for more than three years, there has been an increased demand for commercial properties, the report found.

More than 40% of the states saw an uptick in demand for warehouses, 27% saw an increase in demand for storefronts, and 21% saw an increase in demand for land. For the states that had allowed recreational and medical marijuana the longest, 32% saw commercial leases add addendums addressing growing cannabis while 30% saw addendums concerning cannabis sales.

The NAR report indicates more mixed results on the residential front; states that had legal cannabis markets the longest experienced a 27% drop in residential property values close to cannabis dispensaries while 12% of the states saw an increase in prices. The decreasing property values caused landlords to add addendums to lease agreements, with 58% to 67% of residential property managers in areas with legal recreational cannabis seeing lease addendums that restrict smoking on their premises.

In Colorado and Washington, two states that have relatively successful cannabis industries, an SSRN study indicates that some neighborhoods in both states saw a 7% increase in prices due to newly opened marijuana dispensaries. According to the research, the impact of cannabis legalization on more expensive homes was different from its impact on less-expensive homes, although homes in all price levels saw an increase in value.

As more states legalize cannabis, especially recreational use, real estate markets in these states may see an uptick in homebuyers, including cannabis consumers as well as job seekers. And with more dispensaries opening to cater to the increasing demand, they will need more labor, leading to more demand for homes as more individuals are employed and settle in. Such markets will inevitably be looking at increased property rates coupled with higher rents.

Away from the impact of marijuana on real estate, interesting things are happening as the industry matures. A case in point is RYAH Group Inc., a company that focuses on developing IoT devices that can measure out, remotely, the appropriate quantity of cannabis-based medicines.

NOTE TO INVESTORS: The latest news and updates relating to RYAH Group Inc. are available in the company’s newsroom at https://cnw.fm/RYAH

About CNW420

CNW420 spotlights the latest developments in the rapidly evolving cannabis industry through the release of two informative articles each business day. Our concise, informative content serves as a gateway for investors interested in the legalized cannabis sector and provides updates on how regulatory developments may impact financial markets. Articles are released each business day at 4:20 a.m. and 4:20 p.m. Eastern – our tribute to the time synonymous with cannabis culture. If marijuana and the burgeoning industry surrounding it are on your radar, CNW420 is for you! Check back daily to stay up-to-date on the latest milestones in the fast -changing world of cannabis.

To receive instant SMS alerts, text CANNABIS to 21000 (U.S. Mobile Phones Only)

For more information please visit https://www.CNW420.com

Please see full terms of use and disclaimers on the CannabisNewsWire website applicable to all content provided by CNW420, wherever published or re-published: http://CNW.fm/Disclaimer

Do you have questions or are you interested in working with CNW420? Ask our Editor

CannabisNewsWire420
Denver, Colorado
http://www.CNW420.com
303.498.7722 Office
Editor@CannabisNewsWire.com

CNW420 is part of the InvestorBrandNetwork.

CannabisNewsBreaks – HempFusion Wellness Inc. (TSX: CBD.U) (OTC: CBDHF) (FWB: 8OO) Execs Appear on Leading Cannabis Investing Podcast

HempFusion Wellness (TSX: CBD.U) (OTC: CBDHF) (FWB: 8OO) co-founder and CEO Dr. Jason Mitchell and chief corporate officer Danny Brody were featured on a recent segment of the Cannabis Investing Podcast. The program provides actionable investment insight, context with which to understand the burgeoning cannabis industry, and interviews with C-level executives, scientists, law and sector experts. During their segment, Mitchell and Brody discussed highlights in the cannabis industry, including the recent multibillion deal between GW Pharma and Jazz Pharmaceuticals, as well as radical transparency, the industry’s methodical growth and how companies can become more efficient during COVID-19. They also discussed what makes HempFusion distinctive among other companies operating in the market and prospects of the company going public. From the beginning, HempFusion was committed to compliance, which was a different approach than others operating in the space. That commitment has served the company as the industry has grown and become more regulated; HempFusion is now ahead of the game because it is already compliant. The two also discussed the company’s future strategic plan. Mitchell noted that HempFusion is a completely science-backed company with patented products and proprietary delivery methods, very similar to GW Pharma. “The big fish are now circling,” said HempFusion Wellness co-founder and CEO Dr. Jason Mitchell during the show.

To listen to the podcast, visit https://cnw.fm/Pt08O

About HempFusion Wellness Inc.

HempFusion is a leading health and wellness CBD company utilizing the power of whole-food hemp nutrition. HempFusion distributes its family of brands, including HempFusion, Probulin Probiotics, Biome Research and HF Labs, to approximately 4,000 retailers across all 50 states of the United States and select international locations. Built on a foundation of regulatory compliance and human safety, HempFusion’s diverse product portfolio comprises 46 SKUs (“SKUs”) including tinctures, proprietary FDA Drug Listed over-the-counter (“OTC”) topicals, doctor/practitioner lines and more. With a strong focus on research and development, HempFusion has an additional 30 products under development. HempFusion is a board member of the US Hemp Roundtable, and HempFusion’s wholly owned subsidiary, Probulin Probiotics, is one of the fastest-growing probiotics companies in the United States, according to SPINs reported data. HempFusion’s CBD products are based on a proprietary Whole Food Hemp Complex(TM) and are available in store or online. For more information about the company, visit www.HempFusion.com.

NOTE TO INVESTORS: The latest news and updates relating to HempFusion are available in the company’s newsroom at https://cnw.fm/HempFusion

About CanadianCannabisWire

CanadianCannabisWire (CNW) is an information service that provides (1) access to our news aggregation and syndication servers, (2) CannabisNewsBreaks that summarize corporate news and information, (3) enhanced press release services, (4) social media distribution and optimization services, and (5) a full array of corporate communication solutions. As a multifaceted financial news and content distribution company with an extensive team of contributing journalists and writers, CNW is uniquely positioned to best serve private and public companies that desire to reach a wide audience of investors, consumers, journalists and the general public. CNW has an ever-growing distribution network of more than 5,000 key syndication outlets across the country. By cutting through the overload of information in today’s market, CNW brings its clients unparalleled visibility, recognition and brand awareness. CNW is where news, content and information converge.

To receive instant SMS alerts, text CANNABIS to 21000 (U.S. Mobile Phones Only)

For more information please visit https://www.CanadianCannabisWire.com

Please see full terms of use and disclaimers on the CanadianCannabisWire website applicable to all content provided by CNW, wherever published or re-published: http://CNW.fm/Disclaimer

Do you have a questions or are you interested in working with CNW? Ask our Editor

CanadianCannabisWire (CNW)
Toronto, Ontario
www.CanadianCannabisWire.com
905.674.5977 Office
Editor@CanadianCannabisWire.com

420 with CNW — New Congressional Bill Could Allow CBD, Hemp to Be Sold as Dietary Supplements

The 2018 Farm Bill legalized the cultivation and sale of industrial hemp and hemp extracts, including cannabidiol (“CBD”), spawning what would soon be one of the most popular health and wellness ingredients in a long time. With both hemp and CBD boasting a wide array of benefits, a market products containing the two ingredients sprang up. Although the sector soon had thousands of sellers across the supply chain with CBD products attracting incredible demand, the U.S. Food and Drug Administration (“FDA”) was expressly against marketing and selling CBD products as dietary supplements.

However, thanks to a bill reintroduced into Congress by a bipartisan group of lawmakers, that may soon be a thing of the past. The bill, which was first filed by Representatives Kurt Schrader and Morgan Griffith last year, would allow hemp, hemp-derived CBD, and “any other ingredient derived from hemp” to be used as a dietary supplement under the Federal Food, Drug, and Cosmetic Act. This version of the bill, called the Hemp and Hemp-Derived CBD Consumer Protection and Market Stabilization Act, has 17 other cosponsors alongside the two congressmen.

For quite a while, the FDA has been under pressure to rein in the quickly growing CBD industry, called the “Wild West” by some. However, the agency has maintained that it may take a while to fully regulate CBD, offering enforcement discretion guidance in the meantime while it works on crafting formal rules for CBD. In 2019, a bipartisan coalition of 26 House members sent the FDA a letter saying that the agency’s current regulatory posture has led to significant “regulatory and legal uncertainty.”

The FDA opened a public comment period from April to July of 2019 asking the public to submit information about CBD; the agency reopened the comment period in March 2020. According to the agency, the comment period would allow stakeholders to provide new information in real time to the FDA that would help it “address uncertainties and data gaps” as it crafted CBD regulation.

The U.S. Hemp Roundtable has applauded the move, saying Schrader and Griffith have shown true leadership concerning CBD. Jonathan Miller, general counsel for the Roundtable, anticipates support for the CBD legislation will continue to build as it goes through Congress. The new bipartisan CBD marketing bill increases the number of bills addressing cannabis issues. The second is a bill to move cannabis’ place in the Controlled Substances Act from Schedule I to Schedule III; a third bill prevents the U.S. Department of Veterans from keeping veterans from accessing their benefits because of state-legal medical marijuana use.

In states with legal cannabis markets, innovation in the sector is booming. A clear example is the way in which CannAssist International Corp. (OTCQB: CNSC) is merging the worlds of biotechnology, the wellness industry and the pharmaceuticals industry to create cannabis products that offer consistent results and superior performance in many aspects, including better bioavailability.

NOTE TO INVESTORS: The latest news and updates relating to CannAssist International Corp. (OTCQB: CNSC) are available in the company’s newsroom at https://cnw.fm/CNSC

About CNW420

To receive instant SMS alerts, text CANNABIS to 21000 (U.S. Mobile Phones Only)

For more information please visit https://www.CNW420.com

Please see full terms of use and disclaimers on the CannabisNewsWire website applicable to all content provided by CNW420, wherever published or re-published: http://CNW.fm/Disclaimer

Do you have questions or are you interested in working with CNW420? Ask our Editor

CannabisNewsWire420
Denver, Colorado
http://www.CNW420.com
303.498.7722 Office
Editor@CannabisNewsWire.com

CNW420 is part of the InvestorBrandNetwork.

420 with CNW — How to Determine CBD Serving Sizes

Wise users of CBD try to be as exact as they possibly can when it comes to CBD doses. However, users should keep in mind that since cannabinoids are plants, they may tend go a little overboard if they don’t focus on the results of the quantity taken instead of the number of milligrams in a dose. In addition, with wide variability also being considered, it’s safe to assume that the dose for one product may not be as effective as a similar dose of another product.

Users who are just starting out with cannabinoids, or CBD, or who are trying out a new product, keeping a few things in mind could make the experience better and safe. Users should begin with a small dose before they increase it to a reasonable serving, if need be. Half a drop or a full drop may be a good start. Users can then monitor the results. If there is no results, users can then increase the serving size by a small amount. Following this process should help identify a correct dose that works and produces the desired results.

While it may be difficult to determine a solution’s dose, it may be even more challenging when a user has a specific flower or bud in a cigarette or pipe. Precisely knowing the amount of product that is used in various buds during inhalation is hard because of the wide range of variability.

One good way to determine the correct dose is for users to carefully monitor themselves. Note how they are feeling and responding in order to obtain the results they anticipate.

The same approach should be used for vaping. There’s a lot of variables, which range from how long a person inhales or how long an individual holds smoke in their body. For instance, two users can be vaping in similar situations, but one may inhale for a longer period than the other, resulting in different rates of absorption. Of course, the CBD absorption across the lung membranes may differ. This means that there will be no similar dosage per inhalation even when different individuals use the same vape.

With regard to edibles, one may be able to estimate the number of milligrams in one serving.

However, the most important bit to keep in mind when trying to determine a serving size or dose is to monitor how a user feels. Users need to note that other variables, including stress and anxiety, may also affect how they feel each day, so the result from a specific dosage may vary from day to day and situation to situation.

Taking some time to recognize how product works in the body is very beneficial in helping users identify a dose that works for them. And of course involving medical providers in the journey of using CBD or any cannabis product is highly recommended.

Meanwhile, lots of companies are striking it big in states with regulated cannabis markets. For example, Gage Cannabis Co. is leveraging its premium-quality hardware, vape pens, flower, concentrates and edibles to build a formidable cannabis brand in Michigan.

NOTE TO INVESTORS: The latest news and updates relating to Gage Cannabis Co. are available in the company’s newsroom at https://cnw.fm/GAGE

About CNW420

To receive instant SMS alerts, text CANNABIS to 21000 (U.S. Mobile Phones Only)

For more information please visit https://www.CNW420.com

Please see full terms of use and disclaimers on the CannabisNewsWire website applicable to all content provided by CNW420, wherever published or re-published: http://CNW.fm/Disclaimer

Do you have questions or are you interested in working with CNW420? Ask our Editor

CannabisNewsWire420
Denver, Colorado
http://www.CNW420.com
303.498.7722 Office
Editor@CannabisNewsWire.com

CNW420 is part of the InvestorBrandNetwork.

CannabisNewsBreaks – MAZAKALI CEO Appears on the Budding Report; Talks Cannabis Industry, Investments and More

MAZAKALI CEO Sumit Mehta was a featured guest on this week’s episode of the Budding Report. Hosted by Charles Horton, Melissa Nasits, Christian Shaw and Chris Perri, the weekly show is centered around all thing cannabis. The show focuses on the latest cannabis news and interviews top leaders in the cannabis space. During the show, Mehta covered a broad range of topics, including the cannabis industry as a whole, investing in the space and the current challenges and stresses in today’s world. Mehta also talked about MAZAKALI, a company focused on transforming the health of plants, people, the planet and portfolios through the responsible and ethical allocation of capital. The company is watching and compiling immense pieces of information as it evaluates the current cannabis situation. Mehta is a recognized cannabis strategist, an internationally recognized speaker and the author of the MAZAKALI GreenPaper(R), an authoritative voice on industry trends that after six years of publication now has more than 70,000 subscribers. In 2017, he began forecasting that 2021 would be a pivotal year for cannabis, a prediction that is looking to be accurate as both public and political support for cannabis grows by significant numbers. He began his career more than 20 years ago as a technology analyst for Merrill Lynch. “As I think back now, 25 years later, tech was an industry,” said MAZAKALI CEO Sumit Mehta in the podcast. “When you fast forward to today, it’s a part of every industry. You can’t name one without it. And I view cannabis from quite the same lens and anticipate very healthy growth in the years and decades ahead. Now cannabis is currently an industry, and I think that one would be hard-pressed to name an industry that is untouched by this plant in the decades to come. We do expect it to be the best-performing asset class over the next decade.”

To view the full episode, visit https://cnw.fm/PGtsE

About MAZAKALI

Headquartered in San Francisco, MAZAKALI offers its Digital Capital Investment Platform to the global cannabis complex. Registered Investment Advisors customize investment portfolios via MAZAKALI’s Outsourced Cannabis Investment Officer (“OCIO”) service, and licensed Investment Bankers help operators with capital and M&A services. MAZAKALI’s leadership team began putting cannabis capital to work in 2014 and brings more than 150 years of financial, strategic, legal, compliance and international business experience to clients across the global hemp and nonhemp cannabis (“NHC”) industries. The MAZAKALI GreenPaper(R) has gained authority through knowledge on deep trends in the industry that matter to investors and operators alike. Securities are offered via a licensed broker/dealer. MAZAKALI was founded to counteract the negative consequences of business practices that deplete resources by making investments in sustainable hemp and nonhemp cannabis. By shepherding capital in a responsible and ethical manner, MAZAKALI and its clients envision a world where cannabis capital investment will play a significant role Beyond Impact.

NOTE TO INVESTORS: The latest news and updates relating to MAZAKALI are available in the company’s newsroom at https://ibn.fm/MAZAKALI

About CannabisNewsWire

CannabisNewsWire (CNW) is an information service that provides (1) access to our news aggregation and syndication servers, (2) CannabisNewsBreaks that summarize corporate news and information, (3) enhanced press release services, (4) social media distribution and optimization services, and (5) a full array of corporate communication solutions. As a multifaceted financial news and content distribution company with an extensive team of contributing journalists and writers, CNW is uniquely positioned to best serve private and public companies that desire to reach a wide audience of investors, consumers, journalists and the general public. CNW has an ever-growing distribution network of more than 5,000 key syndication outlets across the country. By cutting through the overload of information in today’s market, CNW brings its clients unparalleled visibility, recognition and brand awareness. CNW is where news, content and information converge.

To receive SMS text alerts from CannabisNewsWire, text “CANNABIS” to 21000 (U.S. Mobile Phones Only)

For more information please visit https://www.CannabisNewsWire.com

Please see full terms of use and disclaimers on the CannabisNewsWire website applicable to all content provided by CNW, wherever published or re-published: http://CNW.fm/Disclaimer

Do you have questions or are you interested in working with CNW? Ask our Editor

CannabisNewsWire (CNW)
Denver, Colorado
www.CannabisNewsWire.com
303.498.7722 Office
Editor@CannabisNewsWire.com

CannabisNewsWire is part of the InvestorBrandNetwork.

HempNewsBreaks – TAAT(TM) Lifestyle & Wellness Ltd.’s (CSE: TAAT) (OTCQB: TOBAF) (FRANKFURT: 2TP2) Hemp-Based Substitute Mimics Traditional Tobacco Cigarette Experience

AAT(TM) (CSE: TAAT) (OTCQB: TOBAF) (FRANKFURT: 2TP2) today announced that, in a world where re-invented consumer packaged goods (“CPG”) of perceived unhealthy or environmentally harmful products are all the rage, the company is attempting to forge its own niche. TAAT is introducing a hemp-based substitute that mimics the experience of a traditional tobacco cigarette in an attempt to steal market share from Big Tobacco, as well as grow sales organically. The company’s cigarettes are formulated using a house blend of CBD-containing hemp called Beyond Tobacco(TM). Hemp is blended with patented ingredients and refined to replicate the experience of a conventional tobacco cigarette-without the addictive effects of nicotine. The company engaged the representation of CROSSMARK Inc., a Tier-1 CPG agency that serves retail channels across North America and Canada. TAAT intends to leverage CROSSMARK’s existing relationships with over 100,000 convenience retailers to expand availability of its products in Ohio, as well as potentially across the United States. “One only has to look at the results CROSSMARK achieved in commercializing another tobacco brand across the United States to know that they have both the experience and know-how to launch a product to an audience of legal-aged smokers, which could assist the company in realizing its objectives for the TAAT(TM) product launch,” said TAAT CEO Setti Coscarella.

To view the full press release, visit https://cnw.fm/CSuxJ

About TAAT(TM) Lifestyle & Wellness Ltd.

The company has developed TAAT(TM), which is a tobacco-free and nicotine-free alternative to traditional cigarettes offered in “Original,” “Smooth” and “Menthol” varieties. TAAT(TM)’s base material is Beyond Tobacco(TM), a proprietary blend that undergoes a patent-pending refinement technique causing its scent and taste to resemble tobacco. Under executive leadership with “Big Tobacco” pedigree, TAAT(TM) was launched first in the United States in Q4 2020 as the company seeks to position itself in the $814 billion* global tobacco industry. For more information, please visit www.TAATGlobal.com.

*British American Tobacco – The Global Market

NOTE TO INVESTORS: The latest news and updates relating to TOBAF are available in the company’s newsroom at https://ibn.fm/TOBAF

About HempWire

HempWire (HW) is a dedicated information provider focused on (1) aggregating hemp-related news, (2) issuing HempNewsBreaks designed to update investors on the latest developments in the hemp market, (3) enhancing corporate news releases, (4) providing full-service distribution and social media offerings to public and private client-partners and (5) designing and implementing all-inclusive corporate communication solutions. HW is strategically positioned within the rapidly expanding hemp sector with a team of journalists working to help a growing roster of public and private companies reach a wide audience of investors, consumers and members of the media. We leverage a vast network of more than 5,000 key syndication outlets to deliver unparalleled visibility, recognition and content to the hemp industry. HempWire (HW) is where HEMP news, content and information converge.

To receive instant SMS alerts, text HEMPWIRE to 21000 (U.S. Mobile Phones Only)

For more information please visit https://www.HempWire.com

Please see full terms of use and disclaimers on the HempWire website applicable to all content provided by HW, wherever published or re-published: https://www.HempWire.com/Disclaimer

Do you have questions or are you interested in working with HW? Ask our Editor

HempWire (HW)
Denver, Colorado
www.HempWire.com
303.498.7722 Office
Editor@HempWire.net

HempWire is part of the InvestorBrandNetwork.

Green Hygienics Holdings Inc. (GRYN) Owns Largest Single USDA-Certified Organic Hemp Farm in NA; Presents Unique Potential in Growing Industry

Report notes that farmers devoted fewer acreage to cultivating hemp last year
Hemp sales projected to balloon from $1.9 billion in 2020 to $6.9 billion in 2025, a threefold increase over five years
GRYN hemp farm is an 824-acre, USDA-certified organic farm including an additional 400,000 square feet of indoor greenhouse space

Despite significant growth in the CBD and hemp industry last year, licensed hemp acreage decreased in 2020 for the first time since the 2014 U.S. Farm Bill (https://cnw.fm/Anh6F). As the owner and operator of the largest single USDA-certified organic hemp farm in North America, Green Hygienics Holdings (OTCQB: GRYN) is looking to leverage its position as a prime provider of quality hemp as demand is projected to continue to increase.

“For all the growth that the hemp and CBD industry has seen as a nascent industry in recent years, last year farmers took a step back and devoted fewer resources to the crop – the enthusiasm of previous years tempered by oversupply, supply-chain issues and a lack of infrastructure,” stated a recent “Hemp Industry Daily” article. “Licensed hemp acreage decreased in 2020 for the first time since the 2014 U.S. Farm Bill established a national hemp pilot program. Licensed acres dropped to about 375,000 acres — down 27% from an estimated 511,000 acres in 2019. And less than a third of those acres were planted in 2020.”

According to Nielsen Global Connect, a division of Nielsen that focuses on data for manufacturers and retailers, “hemp’s 2020 sales of $1.9 billion will balloon to $6.9 billion in 2025, a threefold increase over five years.”

Called a “sleeping giant,” Green Hygienics owns an 824-acre, USDA-certified organic hemp farm including an additional 400,000 square feet of greenhouse space. GRYN’s farm represents a critical supply chain solution in a space where dwindling acres make property and cultivation an invaluable commodity.

Facing a growing market, the ability to provide volume and consistency will become an essential piece of a successful venture. Green Hygienics maintains these attributes and can produce safe and consistent product on a large scale — outdoors in the field and hemp year-round indoors in the greenhouses — making it an attractive candidate, both as a supplier and as an investment, for savvy investors eyeing the growing potential the market provides.

Green Hygienics is a California-based, innovative, technology-driven enterprise focused on the high-standard cultivation and processing of industrial hemp and manufacturing of pharmaceutical-grade bioactive cannabinoids. The company’s mission is to adhere to the highest standards of operations in consistently delivering safe and premium-quality products to consumers as well as to partnering with CPG (consumer-packaged-goods) and pharmaceutical companies.

For more information, visit the company’s website at www.GreenHygienics.com.

NOTE TO INVESTORS: The latest news and updates relating to GRYN are available in the company’s newsroom at http://cnw.fm/GRYN

About HempWire

To receive instant SMS alerts, text HEMPWIRE to 21000 (U.S. Mobile Phones Only)

For more information please visit https://www.HempWire.com

Please see full terms of use and disclaimers on the HempWire website applicable to all content provided by HW, wherever published or re-published: https://www.HempWire.com/Disclaimer

Do you have a questions or are you interested in working with HW? Ask our Editor

HempWire (HW)
Denver, Colorado
www.HempWire.com
303.498.7722 Office
Editor@HempWire.net

HempWire is part of the InvestorBrandNetwork.

420 with CNW — Highlights from Arizona’s 2020 End-of-Year Marijuana Report

The State of Arizona Department of Health Services recently released its 2020 end-of-year report. It came as no surprise that, for the eighth year in a row, medical cannabis sales rose significantly.

According to the report, Arizonans bought 106 tons of marijuana products from dispensaries this year. Many predict that this number this will only increase in 2021, largely due to the fact that it is now legal for adults to purchase recreational marijuana in the state. This legislative change went into effect on Jan. 22, 2021.

Between recreational marijuana and medical marijuana, dispensary firms in the state plan on expanding almost three times as much cannabis this year.

Arizona Dispensaries Association executive director Sam Richard stated that while the growth in recreational cannabis in Arizona remains to be seen, some of the increase in revenue will be as a result of higher prices in the first months of recreational cannabis sales.

Regardless of the reason, the state’s medical marijuana program is stronger than that of other states that have transitioned to recreational marijuana. Richard stated that he expects many medical marijuana consumers to hold onto their cards, which will help them avoid the 16% excise tax imposed on recreational marijuana products.

Last year, the state’s medical marijuana program was extremely popular, with the population of card-holding patients growing to 295,295 as the year came to a close. This is a 34% increment over 2019’s figures. However, those numbers are only slightly higher when compared to the 25% increase between 2018–2019.

The report also shows that despite the coronavirus pandemic pushing many people in the country to consume more cannabis, alcohol and other drugs, legal cannabis sales did not grow significantly. This can be seen when the growth rate of 2019 over 2018 is 25% when compared to the 2020 growth rate of 29%. However, since 2013, the growth in dispensary sales in the state of Arizona has surpassed 4140%.

The report also showed that last year, the sale of edibles decreased, with dispensaries in the state selling edibles weighing 2.5 tons, which was a 16% reduction when compared to 2019 edible sales, which measured 2.99 tons.

The state recorded a growth in the sales of “other products,” which include vape-pen cartridges and concentrates such as shatter. In comparison with 2019 sales of “other products,” which totaled 4.6 tons, 2020 records show that 8.8 tons were sold, which more than made up for the reduction in edible sales. However, the number of caregivers who were permitted to cultivate cannabis decreased significantly, dropping from 273 to a mere seven authorized caregivers.

Away from the successes registered by the cannabis sector in Arizona, lots of companies are also thriving in this industry. For example, The Alkaline Water Company Inc. (NASDAQ: WTER) (CSE: WTER) recently entered the CBD market by unveiling several products, including salves, tinctures, gummies and capsules, under its A88CBD line.

NOTE TO INVESTORS: The latest news and updates relating to The Alkaline Water Company Inc. (NASDAQ: WTER) (CSE: WTER) are available in the company’s newsroom at http://cnw.fm/WTER

About CNW420

To receive instant SMS alerts, text CANNABIS to 21000 (U.S. Mobile Phones Only)

For more information please visit https://www.CNW420.com

Please see full terms of use and disclaimers on the CannabisNewsWire website applicable to all content provided by CNW420, wherever published or re-published: http://CNW.fm/Disclaimer

Do you have questions or are you interested in working with CNW420? Ask our Editor

CannabisNewsWire420
Denver, Colorado
http://www.CNW420.com
303.498.7722 Office
Editor@CannabisNewsWire.com

CNW420 is part of the InvestorBrandNetwork.

420 with CNW — Virginia Legislators Pass Pivotal Cannabis Legalization Bills

The past few years have seen a wave of cannabis reform sweep across the United States. By the end of 2020, more than 30 states had legalized either recreational or medical cannabis, and several others were considering decriminalizing the controversial drug. The wave of cannabis reform has now reached the South after lawmakers in Virginia passed two cannabis legalization bills, making Virginia the 16th state in the country and the first in the South to legalize recreational cannabis.

However, a legislative committee will have to iron out the differences between the two pieces of legislation for Virginia to move forward with legalization. Since Gov. Ralph Northam and top state lawmakers unveiled a cannabis legalization proposal, several committees and subcommittees have gone through and amended the bills. The House approved the first bill in a 55-42 vote, and hours later, the Senate approved its legalization proposal with a 23-15 vote.

According to Sen. Adam Ebbin, sponsor of the bill, cannabis prohibition in the Commonwealth of Virginia has “clearly failed.” He calls the bill a forward-thinking, deliberative approach to create a regulated recreational cannabis market in the state. Speaking on the floor, he noted that the legislation will help reform Virginia’s criminal system and start the long process of undoing the harm caused by the decades’ long war on drugs.

During the floor debate, delegate Don Scott said the proposal would “provide social equity” and help improve the communities that have been most impacted and harmed by cannabis prohibition. The House version of the bill will head to the Senate while the Senate version would go to the House for consideration. A bicameral conference committee will be created to resolve the differences between the two bills and merge them into one proposal that the legislature will send to the governor’s desk.

One major difference that the committee will have to resolve is whether vertical integration will be allowed once the state launches its recreational cannabis market. At the moment, the bills would not allow the existing four vertically integrated medical marijuana operators in the state to transition to the recreational market. Additionally, the bills also call for launching a recreational cannabis market a year later than Northam wanted on Jan. 1, 2024.

Such a delay would give lawmakers enough time to create the Cannabis Control Authority, an independent agency to oversee the recreational cannabis market and to develop rules and regulations. Ebbin supports the delay, saying it will take time to do things right and launch the state’s cannabis market.

Virginia’s legalization issues aside, companies in other jurisdictions are thriving. A clear example is Grapefruit USA Inc. (OTCQB: GPFT), which has specialized in cannabis manufacturing, distribution and addressing the lifestyle needs of consumers under its Rainbow Dreams brand.

NOTE TO INVESTORS: The latest news and updates relating to Grapefruit USA Inc. (OTCQB: GPFT) are available in the company’s newsroom at http://cnw.fm/GPFT

About CNW420

To receive instant SMS alerts, text CANNABIS to 21000 (U.S. Mobile Phones Only)

For more information please visit https://www.CNW420.com

Please see full terms of use and disclaimers on the CannabisNewsWire website applicable to all content provided by CNW420, wherever published or re-published: http://CNW.fm/Disclaimer

Do you have questions or are you interested in working with CNW420? Ask our Editor

CannabisNewsWire420
Denver, Colorado
http://www.CNW420.com
303.498.7722 Office
Editor@CannabisNewsWire.com

CNW420 is part of the InvestorBrandNetwork.

CannabisNewsBreaks – MAZAKALI CEO Authors Article on Healing Properties of Cannabis

MAZAKALI CEO Sumit Mehta authored a recent News Media online article titled “Cannabis = Indian Medicine, Is One of Humankind’s Most Ancient Healing Herbs.” MAZAKALI is a cannabis-focused fintech marketplace that offers full-scale digital capital raising and investment services across the cannabis complex, including hemp, real estate, supply chain, ancillary and international. In the article, Mehta explains that more than 100 medical applications of cannabis were recorded as far back as 2737 by the father of Chinese medicine, Emperor Shen Nung. Uses for the substance have continued to increase, with scientists in 1992 identifying a previously undiscovered regulation system within the human body, the endocannabinoid system (“ECS”), which is a collection of cell receptors responsible for maintaining internal homeostasis, or stable balance, through the synthesis of cannabinoids — the same chemical compounds found in the cannabis plant — that are produced by the body. Today, one of the most common uses for medical cannabis is for pain control, although many are eyeing the plant as potential treatment for many of the same illnesses it was used for thousands of years ago. “The world is once again recognizing cannabis as safer than opiates (it is not possible to overdose and is less addictive than caffeine) and as a replacement for modern pain medication,” Mehta writes in the article. “Two recent studies published in the 110-year-old medical journal JAMA Internal Medicine indicate the rate of opiate prescriptions is lower in states where medical cannabis laws have been passed. The U.S. National Library of Medicine lists over 90 active studies currently being done in the space of cannabis medicine and directed toward the 500+ known compounds found in the plant.”

For more information, visit https://cnw.fm/v7fqg

About MAZAKALI

NOTE TO INVESTORS: The latest news and updates relating to MAZAKALI are available in the company’s newsroom at https://ibn.fm/MAZAKALI

About CannabisNewsWire

To receive SMS text alerts from CannabisNewsWire, text “CANNABIS” to 21000 (U.S. Mobile Phones Only)

For more information please visit https://www.CannabisNewsWire.com

Please see full terms of use and disclaimers on the CannabisNewsWire website applicable to all content provided by CNW, wherever published or re-published: http://CNW.fm/Disclaimer

Do you have questions or are you interested in working with CNW? Ask our Editor

CannabisNewsWire (CNW)
Denver, Colorado
www.CannabisNewsWire.com
303.498.7722 Office
Editor@CannabisNewsWire.com

CannabisNewsWire is part of the InvestorBrandNetwork.